Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This bureaucratic requirement may frustrate access to PrEP in the U.S. region where the HIV epidemic is the most severe.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
A low-cost generic version of Truvada as PrEP will hit the market September 30.
POZ readers provide feedback on how the coronavirus pandemic has affected their lives.
In 2014, the Affordable Care Act allowed states to expand their Medicaid programs.
A coalition of LGBT groups sues the Trump administration over the rule. The lawsuit is “Whitman-Walker Clinic v. HHS.”
Hint: Gilead Sciences donated the meds for Trump’s HIV prevention program, so that cost isn’t the issue.
Here’s how HIV funding from the CARES Act gets divided
During the COVID-19 crisis, some insurers are relaxing their refill rules and allowing 90-day supplies of meds to be prescribed.
However, Latinos are still less likely to have coverage compared with whites.
Fact-checkers and HIV advocates break down the president’s State of the Union boasts.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
But that doesn’t mean the Affordable Care Act is safe. Here’s what’s up next.
Beginning January 1, pharmacists can provide an initial supply of the pills that prevent HIV.
Data from 2018 show a record low number of new HIV cases and a huge increase in people taking PrEP.
Changes to the Title X program concern abortion and target Planned Parenthood. But they should alarm the HIV community.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.